Kratos Q2 Revenue Beat Confirms Top-Line Momentum, but Cash Conversion Remains the Key Test
Read source articleWhat happened
Kratos reported Q2 2026 revenue of $458.8M, up 30.5% YoY with EPS beat of $0.06, driven by 50.2% growth in defense rocket support, 43.3% in turbine technologies, and 29.5% in microwave products. Consolidated organic growth was 19.1%, with Kratos Government Solutions up 22% and Unmanned Systems up 8.1%, showing broad but uneven strength. The print supports management's full-year revenue guidance but does not yet reveal whether funded backlog expanded, DSO improved, or operating cash flow turned less negative. Prior concerns about working-capital strain and negative free cash flow remain unresolved, as the article focuses on revenue and margin beats rather than balance-sheet conversion. While the revenue acceleration may reduce some speculative premium, the stock's valuation and cash-flow profile still demand evidence of sustained production scalability before a rating upgrade is warranted.
Implication
Investors should view the Q2 report as a positive but incomplete data point: revenue momentum supports the top-line story, yet KTOS still trades on 73x EV/EBITDA and negative FCF. Over the next 3-6 months, the critical thresholds are DSO trending below 130 days, inventory growth not outpacing revenue, and new Valkyrie follow-on awards. If Q3 shows those improvements, the WAIT could shift to a BUY near the $42 attractive entry; if not, the bear case remains relevant and the stock likely reverts toward the low-$40s. Patience is warranted until the company proves it can convert growth into cash and expand production beyond the initial 24-unit Valkyrie lot.
Thesis delta
The Q2 revenue and EPS beat modestly strengthens the top-line execution narrative but does not resolve the core cash-flow and backlog-conversion concerns that anchor the WAIT rating. The thesis remains intact, with a slight positive tilt, as revenue growth across key lines de-risks near-term guidance but not the longer-term working-capital and free-cash-flow challenges. No change in rating is justified until Q3 prints show funded backlog growth and operational cash flow improvement.
Confidence
Medium-High